Executive Management

Graduated of the University of Łódź, Faculty of Management. He is qualified by ACCA (British Association of Chartered Certified Accountants) and Certified Internal Auditor (The Institute of Internal Auditors from the USA). He started his professional career in the audit departments of PWC and EY. For many years he has been performing managerial functions in the area of ​​finance and audit. For 14 years he worked in various positions in the Agora S.A. Group. (including financial reporting manager, internal audit manager of a capital group and financial director), then as a member of the management board for financial matters and financial director at Platige Image S.A., Audioteka S.A., Dobroplast Fabryka Okien Sp. z o.o, (after the acquisition of this company by the Arbonia A.G. Group). On August 23, 2021, he was appointed a member of the management board for financial matters at Medicalgorithmics S.A.

Mr. Przemysław Tadla has 23 years of professional experience gained in large, international corporations operating in the electronics, automotive, product certification and medical industries.

Since 2008, he has been dealing with the assessment of compliance with safety requirements and the certification of products for the US market and the most important international markets. From Medicalgorithmics S.A. he was tied up from mid-2013 to 2021. He held several positions, including the head of the Strategy Development Department and the Plenipotentiary for the Quality Management System at the Management Board. As the Strategy Director, he was responsible for supporting the Company's Management Board in developing, communicating, implementing and maintaining the Company's strategic initiatives. Among the most important projects for which he was responsible was the design of the new system for hybrid cardiac rehabilitation PocketECG CRS, which ended with CE and FDA certification in 2018. In addition, for many years as the Product Compliance Director, he supervised the Company's medical device certification department, which was responsible for all regulatory matters regarding medical devices, including certificates and registrations around the world. In the last period of work for Medicalgorithmics S.A. as the Operations Director, he managed the Company's production plant.

After leaving Medicalgorithmics S.A. started his activity as a consultant in RASC Sp. z o. o. and cooperated with companies from the med-tech industry from Europe and the United States, supporting them in the field of product development, certification and marketing approval strategies. From the beginning of 2022, as the Operations Director, he is responsible for product development in American startups Biometryks LLC and Kardiolytics Inc.

Mr. Przemysław Tadla is a graduate of the Poznań University of Technology and post-graduate studies at the Warsaw School of Economics.

Mr. Przemysław Tadla will be responsible for the technology area in the Management Board as Chief Technology Officer.

James brings 20 years of extensive experience in sales and business development roles specifically in the cardiac monitoring space in the US. At Medicalgorithmics, he is responsible for strengthening client relationships, expanding distribution channels, and developing sales growth initiatives for the North American market, particularly in the United States.

James is a highly competitive professional with extensive experience in sales, sales leadership, and business development roles, specializing in quickly building teams that create brand value and drive sales. He has a deep understanding of the cardiac monitoring and medical technology industries. His recent experience includes successfully developing and implementing sales and marketing strategies for digital health and remote patient monitoring services. He has also been extensively involved in strategic planning, building, and managing sales teams.

Prior to joining Medicalgorithmics, James was an Area Director Digital Health and Diagnostic Monitoring at Biotronik. He also worked as a Sales Director at Bardy Diagnostics (now Baxter). In these positions, he had responsibility for managing sales teams and had an active involvement in all aspects of business development.